Relación precio/ingresos de explotación (P/OP)
desde 2005
Cálculo
Amgen Inc., P/OP, tendencias a largo plazocálculo
| P/OP | = | Precio de la acción1, 2, 3 | ÷ | Beneficio operativo por acción1 | Beneficio operativo por acción1 | = | Resultado de explotación1 (en millones) |
÷ | Número de acciones ordinarias en circulación2 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 14 feb. 2024 | 19.69 | = | 290.07 | ÷ | 14.74 | 14.74 | = | 7,897 | ÷ | 535,918,901 | |
| 9 feb. 2023 | 13.40 | = | 240.00 | ÷ | 17.91 | 17.91 | = | 9,566 | ÷ | 533,976,238 | |
| 16 feb. 2022 | 16.24 | = | 222.66 | ÷ | 13.71 | 13.71 | = | 7,639 | ÷ | 557,029,370 | |
| 9 feb. 2021 | 14.96 | = | 236.65 | ÷ | 15.82 | 15.82 | = | 9,139 | ÷ | 577,566,383 | |
| 12 feb. 2020 | 13.84 | = | 227.00 | ÷ | 16.40 | 16.40 | = | 9,674 | ÷ | 589,806,819 | |
| 13 feb. 2019 | 11.46 | = | 188.98 | ÷ | 16.49 | 16.49 | = | 10,263 | ÷ | 622,278,034 | |
| 13 feb. 2018 | 12.71 | = | 175.94 | ÷ | 13.84 | 13.84 | = | 9,973 | ÷ | 720,562,246 | |
| 14 feb. 2017 | 12.64 | = | 168.05 | ÷ | 13.30 | 13.30 | = | 9,794 | ÷ | 736,452,791 | |
| 16 feb. 2016 | 13.07 | = | 147.15 | ÷ | 11.26 | 11.26 | = | 8,470 | ÷ | 752,091,038 | |
| 19 feb. 2015 | 19.13 | = | 156.05 | ÷ | 8.16 | 8.16 | = | 6,191 | ÷ | 758,861,306 | |
| 24 feb. 2014 | 16.19 | = | 125.79 | ÷ | 7.77 | 7.77 | = | 5,867 | ÷ | 755,007,290 | |
| 27 feb. 2013 | 12.22 | = | 91.03 | ÷ | 7.45 | 7.45 | = | 5,577 | ÷ | 748,430,018 | |
| 29 feb. 2012 | 12.48 | = | 68.01 | ÷ | 5.45 | 5.45 | = | 4,312 | ÷ | 791,432,134 | |
| 25 feb. 2011 | 8.79 | = | 52.26 | ÷ | 5.95 | 5.95 | = | 5,545 | ÷ | 932,452,902 | |
| 1 mar. 2010 | 10.12 | = | 56.90 | ÷ | 5.62 | 5.62 | = | 5,506 | ÷ | 979,301,627 | |
| 27 feb. 2009 | 9.70 | = | 48.93 | ÷ | 5.04 | 5.04 | = | 5,214 | ÷ | 1,033,964,089 | |
| 28 feb. 2008 | 12.44 | = | 45.53 | ÷ | 3.66 | 3.66 | = | 3,980 | ÷ | 1,087,627,536 | |
| 28 feb. 2007 | 19.54 | = | 64.26 | ÷ | 3.29 | 3.29 | = | 3,840 | ÷ | 1,167,458,942 | |
| 10 mar. 2006 | 17.96 | = | 73.49 | ÷ | 4.09 | 4.09 | = | 4,848 | ÷ | 1,184,633,787 |
Basado en los informes: 10-K (Fecha del informe: 2023-12-31), 10-K (Fecha del informe: 2022-12-31), 10-K (Fecha del informe: 2021-12-31), 10-K (Fecha del informe: 2020-12-31), 10-K (Fecha del informe: 2019-12-31), 10-K (Fecha del informe: 2018-12-31), 10-K (Fecha del informe: 2017-12-31), 10-K (Fecha del informe: 2016-12-31), 10-K (Fecha del informe: 2015-12-31), 10-K (Fecha del informe: 2014-12-31), 10-K (Fecha del informe: 2013-12-31), 10-K (Fecha del informe: 2012-12-31), 10-K (Fecha del informe: 2011-12-31), 10-K (Fecha del informe: 2010-12-31), 10-K (Fecha del informe: 2009-12-31), 10-K (Fecha del informe: 2008-12-31), 10-K (Fecha del informe: 2007-12-31), 10-K (Fecha del informe: 2006-12-31), 10-K (Fecha del informe: 2005-12-31).
1 US$
2 Datos ajustados por divisiones y dividendos de acciones.
3 Precio de cierre a la fecha de presentación del informe anual de Amgen Inc.
Comparación con la competencia
Amgen Inc., P/OP, tendencias a largo plazo, comparación con los competidores
| Amgen Inc. | AbbVie Inc. | Danaher Corp. | Gilead Sciences Inc. | Moderna Inc. | Regeneron Pharmaceuticals Inc. | Thermo Fisher Scientific Inc. | |
|---|---|---|---|---|---|---|---|
| 14 feb. 2024 | 19.69 | 24.34 | 35.64 | 12.05 | — | 25.39 | 31.16 |
| 9 feb. 2023 | 13.40 | 14.78 | 20.97 | 14.21 | 5.71 | 18.01 | 25.30 |
| 16 feb. 2022 | 16.24 | 14.21 | 25.14 | 7.76 | 4.59 | 7.55 | 21.07 |
| 9 feb. 2021 | 14.96 | 16.32 | 36.91 | 19.38 | — | 14.82 | 22.81 |
| 12 feb. 2020 | 13.84 | 10.82 | 34.47 | 20.66 | — | 19.01 | 26.84 |
| 13 feb. 2019 | 11.46 | 18.35 | 23.18 | 10.15 | — | 17.53 | 27.33 |
| 13 feb. 2018 | 12.71 | 19.63 | 22.48 | 7.45 | — | 16.71 | 28.24 |
| 14 feb. 2017 | 12.64 | 10.49 | 21.37 | 5.23 | — | 28.70 | 25.13 |
| 16 feb. 2016 | 13.07 | 11.61 | 17.27 | 5.50 | — | 30.74 | 22.15 |
| 19 feb. 2015 | 19.13 | 28.64 | 17.94 | 10.19 | — | 49.17 | 20.63 |
| 24 feb. 2014 | 16.19 | 14.31 | 16.24 | 28.54 | — | 42.99 | 30.40 |
| 27 feb. 2013 | 12.22 | 10.44 | 13.40 | 16.28 | — | 35.11 | 17.92 |
| 29 feb. 2012 | 12.48 | — | 14.04 | 9.02 | — | — | 16.64 |
| 25 feb. 2011 | 8.79 | — | 15.14 | 7.82 | — | — | 17.09 |
| 1 mar. 2010 | 10.12 | — | 15.63 | 12.16 | — | — | 19.04 |
| 27 feb. 2009 | 9.70 | — | 8.85 | 15.24 | — | — | 12.33 |
| 28 feb. 2008 | 12.44 | — | 13.65 | 18.80 | — | — | 24.03 |
| 28 feb. 2007 | 19.54 | — | 14.52 | — | — | — | 79.09 |
| 10 mar. 2006 | 17.96 | — | 15.18 | 25.01 | — | — | 21.48 |
Basado en los informes: 10-K (Fecha del informe: 2023-12-31), 10-K (Fecha del informe: 2022-12-31), 10-K (Fecha del informe: 2021-12-31), 10-K (Fecha del informe: 2020-12-31), 10-K (Fecha del informe: 2019-12-31), 10-K (Fecha del informe: 2018-12-31), 10-K (Fecha del informe: 2017-12-31), 10-K (Fecha del informe: 2016-12-31), 10-K (Fecha del informe: 2015-12-31), 10-K (Fecha del informe: 2014-12-31), 10-K (Fecha del informe: 2013-12-31), 10-K (Fecha del informe: 2012-12-31), 10-K (Fecha del informe: 2011-12-31), 10-K (Fecha del informe: 2010-12-31), 10-K (Fecha del informe: 2009-12-31), 10-K (Fecha del informe: 2008-12-31), 10-K (Fecha del informe: 2007-12-31), 10-K (Fecha del informe: 2006-12-31), 10-K (Fecha del informe: 2005-12-31).